Macrogenics Inc (MGNX)

Insider Selling: Peters Jeffrey Stuart, Macrogenics Inc [MGNX] Senior VP and General Counsel divested 51395 shares ... - Knox Daily

Knox Daily

Strength Seen in MacroGenics (MGNX): Can Its 25.7% Jump Turn into More Strength? - Yahoo Lifestyle UK

Yahoo Lifestyle UK

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MacroGenics, Inc. - MGNX - PR Newswire

PR Newswire

MacroGenics (MGNX) Stock Crashes After Reporting Patient Deaths in TAMARACK Study – Hagens Berman - GlobeNewswire

GlobeNewswire

2024-05-16 | NDAQ:MGNX | Press Release | MacroGenics Inc - Stockhouse Publishing

Stockhouse Publishing

Q2 2024 EPS Estimates for MacroGenics, Inc. (NASDAQ:MGNX) Cut by HC Wainwright - Defense World

Defense World

MacroGenics Plunges On Prostate Cancer ADC Safety Concerns - Scrip

Scrip

MacroGenics, Inc. to Post Q2 2024 Earnings of ($0.70) Per Share, HC Wainwright Forecasts (NASDAQ:MGNX) - MarketBeat

MarketBeat

2024-05-15 | NDAQ:MGNX | Press Release | MacroGenics Inc - Stockhouse Publishing

Stockhouse Publishing

MACROGENICS ALERT: Bragar Eagel & Squire, P.C. is Investigating MacroGenics, Inc. on Behalf of MacroGenics ... - GlobeNewswire

GlobeNewswire

Equities Analysts Set Expectations for MacroGenics, Inc.'s Q1 2025 Earnings (NASDAQ:MGNX) - Defense World

Defense World

MacroGenics (NASDAQ:MGNX) Price Target Cut to $4.00 - Defense World

Defense World

Why Akamai Technologies, NuVasive, and MacroGenics Jumped Today - Yahoo News UK

Yahoo News UK

MACROGENICS ALERT: Bragar Eagel & Squire, P.C. is Investigating MacroGenics, Inc. on Behalf of MacroGenics Stockholders and Encourages Investors to Contact the Firm - ForexTV.com

ForexTV.com

Clinical Report: MacroGenics faces ADC safety concerns - BioCentury

BioCentury

MacroGenics, Inc. Consensus Forecasts Have Become A Little Darker Since Its Latest Report - Yahoo Lifestyle UK

Yahoo Lifestyle UK

HC Wainwright Comments on MacroGenics, Inc.'s Q1 2025 Earnings (NASDAQ:MGNX) - MarketBeat

MarketBeat

MacroGenics, Inc. (MGNX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek ... - AccessWire

AccessWire

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against MacroGenics, Inc. and ... - Morningstar

Morningstar

JMP Securities Lowers MacroGenics (NASDAQ:MGNX) Price Target to $16.00 - Defense World

Defense World

HC Wainwright Trims MacroGenics (NASDAQ:MGNX) Target Price to $4.00 - MarketBeat

MarketBeat

Kirby McInerney LLP Announces Investigation of Shareholder Claims Against MacroGenics, Inc. (MGNX) - Business Wire

Business Wire

Brokers Are Upgrading Their Views On MacroGenics, Inc. (NASDAQ:MGNX) With These New Forecasts - Yahoo Movies UK

Yahoo Movies UK

MacroGenics (MGNX) to Report Q1 Results: Wall Street Expects Earnings Growth - Yahoo Lifestyle UK

Yahoo Lifestyle UK

MacroGenics, Inc. (MGNX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek ... - AccessWire

AccessWire

MacroGenics to Participate in Upcoming Investor Conferences - GlobeNewswire

GlobeNewswire

MacroGenics shares target cut by H.C. Wainwright on trial safety concerns - Investing.com Canada

Investing.com Canada

MacroGenics shares target cut by H.C. Wainwright on trial safety concerns - Investing.com South Africa

Investing.com South Africa

MacroGenics, Inc.'s (NASDAQ:MGNX) 81% Dip In Price Shows Sentiment Is Matching Revenues - Simply Wall St

Simply Wall St

MacroGenics to Participate in Upcoming Investor Conferences - Yahoo Finance UK

Yahoo Finance UK

MacroGenics: Strong Likelihood Bad News Has Caused Overreaction (Rating Upgrade) (MGNX) - Seeking Alpha

Seeking Alpha

MacroGenics (NASDAQ:MGNX) Price Target Cut to $14.00 - Defense World

Defense World

MacroGenics (NASDAQ:MGNX) Downgraded by TD Cowen to “Hold” - Defense World

Defense World

MacroGenics Sees Hammer Chart Pattern: Time to Buy? - Yahoo Lifestyle Australia

Yahoo Lifestyle Australia

US$15.10: That's What Analysts Think MacroGenics, Inc. (NASDAQ:MGNX) Is Worth After Its Latest Results - Yahoo Finance UK

Yahoo Finance UK

StockWatch: MacroGenics Shares Crater after Trial Deaths - Genetic Engineering & Biotechnology News

Genetic Engineering & Biotechnology News

MacroGenics (MGNX) Stock Forecast and Price Target 2024 - MarketBeat

MarketBeat

MacroGenics First Quarter 2024 Earnings: Misses Expectations - Simply Wall St

Simply Wall St

MacroGenics stock downgraded amid safety concerns - Investing.com ZA - Investing.com South Africa

Investing.com South Africa

MacroGenics stock downgraded amid safety concerns By Investing.com - Investing.com Australia

Investing.com Australia

MacroGenics stock downgraded amid safety concerns - Investing.com India

Investing.com India

MacroGenics stock downgraded amid safety concerns By Investing.com - Investing.com Canada

Investing.com Canada

Stifel Downgrades MacroGenics (MGNX) - MSN

MSN

Barclays Trims MacroGenics (NASDAQ:MGNX) Target Price to $14.00 - MarketBeat

MarketBeat

Macrogenics Stock Drops 77% After Study Deaths - The Wall Street Journal

The Wall Street Journal

MacroGenics (MGNX) Stock Crashes After Reporting Patient Deaths in TAMARACK Study – Hagens Berman - GlobeNewswire

GlobeNewswire

Macrogenics Inc (MGNX) Q1 2024 Earnings: Misses Revenue Estimates Amidst Ongoing Clinical Developments - GuruFocus.com

GuruFocus.com

MacroGenics (NASDAQ:MGNX) Downgraded by BMO Capital Markets to Market Perform - MarketBeat

MarketBeat

MacroGenics, Inc. (NASDAQ:MGNX) Q1 2024 Earnings Call Transcript - Insider Monkey

Insider Monkey

MacroGenics, Inc. (NASDAQ:MGNX) Q1 2024 Earnings Call Transcript - Yahoo Finance

Yahoo Finance